Nadine Hillock

Ms Nadine Hillock

Higher Degree by Research Candidate

PhD Candidate

School of Public Health

Faculty of Health and Medical Sciences


Nadine Hillock is a public health pharmacist with over 20 years experience across a variety of healthcare sectors, including hospital and community pharmacy, industry and government. She has a strong interest in evidence-based medicine, medicines evaluation, health policy and pharmacoeconomics. She has a Master of Public Health from the University of Sydney and is currently doing a PhD investigating alternative regulatory and funding models for antimicrobial drugs in Australia.

Nadine is currently a PhD candidate in the School of Public Health, investigating alternative regulatory and funding models for antimicrobial drugs in Australia, under the supervision of Professor Tracy Merlin, Professor Jon Karnon and Professor John Turnidge.

    Expand
  • Appointments

    Date Position Institution name
    2019 Senior Pharmacist | Program Manager, National Antimicrobial Utilisation Surveillance Program (NAUSP) SA Health
    2016 - 2019 Public Health Pharmacist (contractor) SA Health
    2016 - 2016 Clinical Pharmacist / Practice Support Drug & Therapeutics Information Service (DATIS), SA Health
    2015 - 2017 Scientific Writer Joanna Briggs Institute
    2015 - 2015 Tutor Public Health, University of Adelaide, Adelaide
    2010 - 2016 Senior Pharmacist / Executive Officer South Australian Medicines Evaluation Panel, SA Health
    2009 - 2010 Project Pharmacist National Antimicrobial Utilisation Serveillance Programs (NAUSP)
    2007 - 2009 Production Pharmacist Flinders Medical Centre, SA Health
    2005 - 2016 Radiopharmacist Lantheus Medical Imaging (formally Bristol-Myers Squibb Medical Imaging)
    1998 - 2004 Community Pharmacist / Dispensary Manager Christchurch, NZ
    1997 - 1997 Aseptic services / Oncology pharmacist Hawkes Bay District Health Board, NZ
    1996 - 1997 Locum hospital pharmacist Australia & UK
    1994 - 1996 Clinical Pharmacist St George Hospital, Sydney
    1993 - 1994 Intern Pharmacist Tairawhiti District Health Board, NZ
  • Awards and Achievements

    Date Type Title Institution Name Country Amount
    2019 Award Neville Derrington Hicks PhD Scholarship in Public Health Policy University of Adelaide Australia
    2017 Scholarship Divisional Scholarship, Faculty of Health Sciences University of Adelaide
    2014 Award SA Health Award - Excellence in non-clinical services (SAMEP) SA Health
  • Education

    Date Institution name Country Title
    2017 University of Adelaide, Adelaide Australia Doctor of Philosophy (enrolled)
    2010 - 2013 University of Sydney, Sydney Australia Master of Public Health
    1997 - 2000 University of Otago, Dunedin New Zealand Post-graduate diploma in Clinical Pharmacy
    1988 - 1992 University of Otago, Dunedin New Zealand Bachelor of Pharmacy
  • Postgraduate Training

    Date Title Institution Country
    Health Technology Assessment University of Adelaide Australia
    Financial Planning Massey University, Palmerston North New Zealand
    Radiation safety & radiopharmaceutical manufacturing BMS Medical Imaging Australia
  • Certifications

    Date Title Institution name Country
    Registered Pharmacist Australian Health Practitioner Regulation Agency (AHPRA)
    Licence to use or handle radioactive substances Environmental Protection Authority (SA)
  • Research Interests

    Expand
  • Journals

    Year Citation
    2020 Hillock, N., Karnon, J., Turnidge, J., & Merlin, T. (2020). Estimating the utilisation of unregistered antimicrobials in Australia. Infection, Disease and Health, 25(2), 82-91.
    DOI
    2020 Hillock, N. T., Merlin, T., Karnon, J., Turnidge, J., & Eliott, J. (2020). Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study. Journal of Antimicrobial Chemotherapy - Antimicrobial Resistance, 2(2).
    DOI
    2019 Hillock, N., Hillock, R., & Warner, M. (2019). Antibacterial envelope to prevent cardiac implantable device infection. New England Journal of Medicine, 381(18), 1782.
    DOI
    2019 Hillock, N., Paradiso, L., Turnidge, J., Karnon, J., & Merlin, T. (2019). Clinical indications treated with unregistered antimicrobials: The regulatory challenges of antimicrobial resistance and access to effective treatment for patients. Australian Health Review, 44(2), 263-269.
    DOI Scopus1
    2018 Hillock, N. T. (2018). Is obesity fake news?. Pharmacy Growth, Research, Innovation and Training, 2(4).
    DOI
    2017 Hillock, N., Heard, S., Kichenadasse, G., Hill, C., & Andrews, J. (2017). Infliximab for ipilimumab-induced colitis: A series of 13 patients. Asia-Pacific Journal of Clinical Oncology, 13(5), e284-e290.
    DOI Scopus9 WoS7 Europe PMC4
    2016 Hillock, N. (2016). The challenge of costly drugs. Australian Prescriber, 39(5), 149.
    DOI
  • Conference Items

    Year Citation
    2019 McNeil, V., Hillock, N., & Warner, M. (2019). The South Australian Expert Advisory Group on Antimicrobial Resistance: 10 years progress and challenges. Poster session presented at the meeting of Australian Society for Antimicrobials 2019. Sydney.
    2019 McNeil, V., Hillock, N., & Warner, M. (2019). The South Australian Expert Advisory Group on Antimicrobial Resistance: 10 years progress and challenges. Poster session presented at the meeting of Australian Society for Antimicrobials 2019. Sydney.
    2019 Hillock, N. T., Turnidge, J., Karnon, J., & Merlin, T. (2019). Policy incentives for a sustainable antibiotic market: the perspective of Australian stakeholders - a qualitative study (poster presentation). Poster session presented at the meeting of Australian Society for Antimicrobials 2019.
    2019 Hillock, N. T., Paradiso, L., Turnidge, J., Karnon, J., & Merlin, T. (2019). Special Access Scheme Category C and antimicrobial drugs - a policy solution or a temporary fix? (poster presentation). Poster session presented at the meeting of Australian Society for Antimicrobials 2019.
    2018 Hillock, N. T. (2018). Antimicrobial drugs and the Special Access Scheme: an anomaly or a marker of a system in crisis (Oral presentation). Poster session presented at the meeting of National Medicines Symposium. Canberra.
    2017 Hillock, N. T., Turnidge, J., Karnon, J., & Merlin, T. (2017). Investigating the utilisation of unregistered antimicrobial drugs in Australia. Poster session presented at the meeting of Florey Postgraduate Research Conference. Adelaide.
    2016 Hillock, N. T. (2016). Nuclear medicine and the clinical pharmacist: a pathway to incorporating radiopharmaceuticals in the medication management process. Poster session presented at the meeting of National Medicines Symposium. Canberra.
    2016 Hillock, N. T. (2016). Starting from scratch: The South Australian Medicines Evaluation Panel (oral presentation). Poster session presented at the meeting of Canadian Agency for Drugs and Technologies in Health (CADTH) Symposium. Ottawa.
    2015 Hillock, N. T., Selva-Nayagam, S., Hill, C., & Gailer, J. (2015). How systematic review methodology can mislead: Adalimumab versus infliximab for the treatment of Hidradenitis suppurativa (poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Melbourne.
    2014 Hillock, N. T., Gailer, J., Rolan, P., & Hill, C. (2014). South Australian Medicines Evaluation Panel: Evolution from inception to now (poster presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane.
    2014 Gailer, J., Hillock, N. T., Hill, C., & Louise, J. (2014). How to count the eggs? An ethical dilemma (poster presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane.
    2014 Louise, J., Della Flora, E., & Hillock, N. (2014). Patient self-funding of high cost medications - what are the ethical issues? (oral presentation). Poster session presented at the meeting of National Medicines Symposium. Brisbane.
    2013 Hillock, N. T., Ward, M., Rolan, P., & Hill, C. (2013). A statewide evaluation process for high cost medicines: The challenges of a poor evidence base (poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Cairns.
    2013 Hillock, N. T., Ward, M., Rolan, P., & Hill, C. (2013). Defibrotide for treatment or prophylaxis of veno-occlusive disease: What is the evidence? (Poster presentation). Poster session presented at the meeting of Medicines Management (SHPA) Conference. Cairns.
  • Internet Publications

    Year Citation
    2016 Hillock, N. T. (2016). Total knee arthroplasty: Continuous passive motion (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Post-stroke fatigue: Assessment (Scales) (Evidence Summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Autism Spectrum Disorders: Omega-3 Fatty Acids (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Autism Spectrum Disorders: Gluten-Free Casein-Free Diet (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Psoriasis: Topical treatments for Chronic Plaque Psoriasis (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Cerebral palsy: Speech and Language Therapy for Communication (Children) (Evidence summary). Joanna Briggs Institute EBP Database.
    2016 Hillock, N. T. (2016). Post-stroke fatigue: Management (Evidence summary). Joanna Briggs Institute EBP Database.
    Expand
  • Committee Memberships

    Date Role Committee Institution Country
    2019 - ongoing Member AMS Advisory Committee ACSQHC Australia
    2019 - ongoing Member Australian Walking and Cycling Conference Organising Committee Australian Walking and Cycling Conference Australia
    2017 - ongoing Member South Australian expert Advisory Group on Antimicrobial Resistance (SAAGAR) SA Health Australia
    2015 - 2017 Member Australian Rheumatology Association - Therapeutics Subcommittee Australia
    2010 - 2016 Co-Founder South Australian Medicines Evaluation Panel SA Health Australia
  • Memberships

    Date Role Membership Country
    2017 - ongoing Australian Society for Infectious Diseases (ASID)
    2017 - ongoing Australian Society of Antimicrobials
    2016 - 2016 Member Health Technology Assessment International (HTAi)
    2014 - ongoing Public Health Association of Australia
    2013 - ongoing International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
    2008 - ongoing Society of Hospital Pharmacists of Australia
  • Review, Assessment, Editorial and Advice

    Date Title Type Institution Country
    2019 - ongoing Peer reviewer, Am J Inf Cont Peer Review American Journal of infection Control
    2019 - ongoing Peer reviewer, Aust Hlth Rev Peer Review Australian Health Review
  • Position: PhD Candidate
  • Phone: 83136580
  • Email: nadine.hillock@adelaide.edu.au
  • Campus: North Terrace
  • Building: Adelaide Health and Medical Sciences, floor 9
  • Room: WS9086.29
  • Org Unit: Adelaide Health Technology Assessment

Connect With Me
External Profiles